Bank of New York Mellon’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-49,270
Closed -$8.01K 4350
2023
Q4
$8.01K Buy
49,270
+3
+0% +$1 ﹤0.01% 4278
2023
Q3
$21.8K Hold
49,267
﹤0.01% 4248
2023
Q2
$18.2K Sell
49,267
-288,206
-85% -$246K ﹤0.01% 4300
2023
Q1
$614K Sell
337,473
-4,147
-1% -$9.01K ﹤0.01% 3383
2022
Q4
$707K Buy
341,620
+19,179
+6% +$60.6K ﹤0.01% 3364
2022
Q3
$970K Buy
322,441
+29,315
+10% +$104K ﹤0.01% 3215
2022
Q2
$938K Buy
293,126
+260,355
+794% +$1.41M ﹤0.01% 3248
2022
Q1
$211K Buy
32,771
+2,928
+10% +$26.5K ﹤0.01% 4208
2021
Q4
$400K Buy
+29,843
New +$328K ﹤0.01% 3936

Other funds holding HLTH

Bank of New York Mellon's HLTH Position: Q1 2024 in Review

Bank of New York Mellon sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 49,270 shares — an estimated $8.01K sold.

Bank of New York Mellon first reported a position in HLTH in Q4 2021 and held it in 9 quarters. The position peaked at $970K in Q3 2022. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

  • Bank of New York Mellon reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 49,270 Cue Health Inc. Common Stock shares in Q1 2024, an estimated $8.01K.
  • Bank of New York Mellon first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Bank of New York Mellon's Cue Health Inc. Common Stock position peaked at $970K in Q3 2022.
  • 57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.